A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon.

BridgeBio spotlights 12 and 18-month data for potential achondroplasia drug in children

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 5, 2024

Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism

A 4-month-old with congenital hyperinsulinism responded well to off-label treatment with a breast cancer drug, researchers reported. A newborn presented with severe congenital hyperinsulinism due

January 25, 2024

Racial and socioeconomic integration linked to lower health care expenditure disparities

Differences in health care expenditures between Black and white adults vary substantially with the local level of racial and economic integration, and tend to be

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.